Several comorbidities are associated with nonalcoholic fatty liver disease, including cardiovascular disease, type 2 diabetes, and sleep apnea. Comorbidities refer to having two or more coexisting ...

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...

In severe cases, the disease progresses to cirrhosis, resulting in irreversible liver damage or liver cancer. Metabolic dysfunction-associated steatotic liver disease affects about one-third of ...

Fatty liver disease is getting more common and now affects about one-third of all people in the world. A lot of people don't care about it because they think it's a small problem that won't get worse ...

Studies show alarming rates of fatty liver disease in young Indians, prompting calls for lifestyle changes and early screenings to combat this silent epidemic. As World Liver Day was observed ...

Acute liver failure (ALF) in children differs from that observed in adults in both the etiologic spectrum and the clinical picture. Children, particularly very young ones, do not demonstrate ...

The liver was not enlarged ... the marrow became completely normal, but neutropenia again developed a month later and the marrow showed failure of maturation beyond the myelocyte stage.

National Organization for Rare Disorders. Cyclic neutropenia. National Institutes of Health. Genetic and Rare Diseases Information Center. Cyclic neutropenia. Centers for Disease Control and ...

French pharma company Genfit has reached a deal to buy Versantis of Switzerland, adding three development-stage drug candidates to its portfolio of experimental liver disease therapies and ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called nonalcoholic fatty liver disease (NAFLD), is a common condition that’s caused by the buildup of fat in the liver.